Medtronic is expanding a recall of two of its MiniMed 600 series insulin pumps after reports found several had broken retainer rings cracked, resulting in insulin doses that were too high or too low.

Medtronic is recalling more than 322,000 of its insulin pumps because of a missing or broken component that can lead to over- or under-delivery of insulin.

Medtronic is recalling MiniMed 600 Series Insulin Pumps. The FDA calls recall Class I the most serious type of recall, which can lead to injury or death.

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...

Medtronic says it has promising data on the effectiveness of its next-generation insulin pump from patients in Europe and Chile. The MiniMed 780G insulin pump, which was cleared in 2020 for use in ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

The M&A news came as Medtronic also released an earnings report summing up its fiscal year 2023, which ended April 28. Altogether, the company took in more than $31.2 billion for the year. Though ...

Medtronic recently received FDA approval for its MiniMed 780G system, which is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ glucose levels every five minutes.

Medtronic's Adapt trial put the algorithm-equipped MiniMed 780G insulin pump to the test against one standard of care for Type 1 diabetes.